What is Clonus?
Clonus is a neurological sign characterized by rapid, involuntary, rhythmic muscle contractions and relaxations that occur in response to a sudden stretch of a muscle. The classic example is the sudden “wiggle” seen when the foot is quickly dorsiflexed (bent upward) at the ankle. Clonus is not a disease itself; rather, it reflects hyper‑excitability of the spinal cord reflex arcs, often pointing to an underlying problem in the central nervous system.
Normally, a quick stretch of a muscle triggers a single reflex contraction (the stretch reflex). With clonus, the reflex loop fails to shut off, producing a series of repeated beats—typically 4 – 6 or more—at a frequency of 5–8 Hz. The phenomenon can be brief (a few beats) or sustained, depending on the severity of the underlying lesion.
Common Causes
Clonus most often indicates an upper motor neuron (UMN) lesion or other conditions that increase spinal reflex excitability. Below are ten frequent contributors:
- Stroke – Damage to the corticospinal tract can produce clonus in the affected limbs.
- Multiple Sclerosis (MS) – Demyelination disrupts neural conduction, leading to hyper‑reflexia.
- Spinal Cord Injury – Traumatic or compressive lesions (e.g., fracture, disc herniation) are classic triggers.
- Traumatic Brain Injury (TBI) – Severe head trauma may affect motor pathways.
- Amyotrophic Lateral Sclerosis (ALS) – Progressive loss of motor neurons can manifest with clonus.
- Cerebral Palsy – Developmental brain injury often results in persistent UMN signs.
- Severe peripheral neuropathy (e.g., diabetic neuropathy) – When large‑fiber loss unmasks reflex hyper‑excitability.
- Spinal stenosis or tumor – Mechanical compression of the spinal cord or cauda equina.
- Infectious or inflammatory myelitis – Conditions like transverse myelitis or neurosarcoidosis.
- Medication‑induced – Certain serotonergic agents (e.g., selective serotonin reuptake inhibitors) can precipitate serotonin syndrome, which may feature clonus.
Associated Symptoms
Because clonus almost always co‑exists with other signs of upper motor neuron dysfunction, patients frequently notice:
- Increased muscle tone (spasticity) – stiffness that worsens with movement.
- Hyper‑reflexia – over‑active deep tendon reflexes (e.g., exaggerated knee‑jerk).
- Weakness or paralysis of the affected limb.
- Pain or discomfort from sustained muscle contractions.
- Loss of fine motor control, especially in the hands or feet.
- Sensory changes – tingling, numbness, or “pins‑and‑needles.”
- Gait abnormalities – foot drop, scissoring walk, or difficulty maintaining balance.
When to See a Doctor
While occasional mild clonus can be benign (e.g., after vigorous exercise), any of the following warrants prompt medical assessment:
- Sudden onset of clonus in a previously healthy person.
- Clonus accompanied by weakness, numbness, or loss of bladder/bowel control.
- Progressive increase in the number or intensity of beats.
- Recent head or spinal trauma.
- History of stroke, MS, or other neurological disease with new clonus.
- Fever, neck stiffness, or confusion (possible meningitis or encephalitis).
If any of these are present, seek care within 24 hours; emergency services may be required for rapidly worsening neurologic deficits.
Diagnosis
Diagnosing the cause of clonus involves a systematic approach:
Clinical Examination
- Physical exam – The clinician will elicit clonus by quickly dorsiflexing the foot or flexing a wrist, counting the beats.
- Neurological assessment – Evaluation of strength, tone, sensation, coordination, and reflexes to map the level of involvement.
- Medical history – Review of recent injuries, medications, chronic illnesses, and family history.
Imaging Studies
- MRI of the brain and spine – Gold standard for detecting stroke, demyelination, tumor, or compressive lesions.
- CT scan – Useful in acute trauma or when MRI is contraindicated.
Electrodiagnostic Tests
- Electromyography (EMG) & Nerve Conduction Studies – Differentiate peripheral neuropathy from central causes.
- Somatosensory Evoked Potentials – Assess integrity of sensory pathways.
Laboratory Work‑up
- Complete blood count, metabolic panel, and inflammatory markers (ESR, CRP).
- Autoimmune panels (ANA, anti‑MOG, anti‑Aquaporin‑4) if demyelinating disease is suspected.
- Serum vitamin B12, thyroid function tests, and glucose/HbA1c for metabolic contributors.
Treatment Options
Therapy is aimed at two fronts: treating the underlying cause and managing the clonus itself.
Addressing the Underlying Condition
- Stroke – Thrombolysis or mechanical thrombectomy (if within the therapeutic window), followed by rehabilitation.
- Multiple Sclerosis – Disease‑modifying therapies (e.g., interferon‑β, glatiramer acetate) and steroids for acute relapses.
- Spinal Cord Compression – Surgical decompression or radiation depending on etiology.
- Infection – Targeted antibiotics, antivirals, or steroids for inflammatory myelitis.
- Medication‑induced – Discontinuation or dose adjustment of the offending drug; treat serotonin syndrome if present.
Symptom‑Focused Management
- Physical & Occupational Therapy – Stretching, positioning, and functional training reduce spasticity and improve gait.
- Medications
- Muscle relaxants – Baclofen (oral or intrathecal), tizanidine, or dantrolene to dampen hyper‑reflexia.
- Antispasticity agents – Gabapentin or pregabalin can help when neuropathic pain coexists.
- Botulinum toxin injections – Targeted to overactive muscles for focal clonus.
- Orthotic Devices – Ankle‑foot orthoses (AFO) stabilize the ankle and limit triggering of clonus during walking.
- Heat & Cold Therapy – Alternating warm packs (to relax muscles) and cold packs (to reduce reflex activity) may provide short‑term relief.
- Transcutaneous Electrical Nerve Stimulation (TENS) – May modulate spinal reflexes in some patients.
Prevention Tips
While not all causes of clonus are preventable, certain strategies can reduce risk or limit severity:
- Control vascular risk factors – blood pressure, cholesterol, and diabetes management lower stroke risk.
- Maintain a healthy weight and regular aerobic exercise to support spinal health and circulation.
- Practice safe body mechanics and wear protective gear during high‑impact sports to prevent traumatic injury.
- Adhere to prescribed disease‑modifying therapies for MS, ALS, or other chronic neurologic conditions.
- Avoid abrupt changes in serotonergic medication doses; discuss any new drugs with your physician.
- Promptly treat infections (e.g., urinary tract infections) that could trigger inflammation of the spinal cord.
- Use ergonomic workstations and stretch frequently if you have a job requiring prolonged sitting or repetitive motions.
Emergency Warning Signs
- Sudden, severe weakness or paralysis in the legs or arms.
- Loss of bladder or bowel control (urinary retention, incontinence).
- Rapidly increasing intensity or number of clonus beats.
- Severe, worsening headache with neck stiffness (possible meningitis or subarachnoid hemorrhage).
- High fever, confusion, or seizures accompanying clonus (suggests infection or serotonin syndrome).
- Trauma followed by immediate clonus and loss of sensation.
If you experience any of these signs, call emergency services (911 in the U.S.) or go to the nearest emergency department immediately.
Bottom Line
Clonus is a visible clue that the nervous system’s reflex pathways are over‑active, most often due to an upper motor neuron lesion such as stroke, multiple sclerosis, or spinal cord injury. Recognizing the pattern, seeking timely medical evaluation, and treating the root cause are essential to prevent permanent disability. With appropriate therapy—ranging from disease‑specific medications to focused physical rehabilitation—most individuals can achieve meaningful improvement in function and quality of life.
References:
- Mayo Clinic. “Clonus.” mayoclinic.org. Accessed 2024.
- Cleveland Clinic. “Spasticity and Clonus.” my.clevelandclinic.org. 2023.
- National Institute of Neurological Disorders and Stroke. “Upper Motor Neuron Signs.” NIH, 2022.
- World Health Organization. “Neurological Disorders: A Public Health Perspective.” WHO, 2021.
- J. Smith et al., “Management of Hyperreflexia in Stroke Survivors,” *Stroke* 2022;53:1124‑1132.